Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2005
06/01/2005EP1534281A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace)
06/01/2005EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
06/01/2005EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use
06/01/2005EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
06/01/2005EP1534272A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
06/01/2005EP1534268A2 Tyrosine kinase inhibitors
06/01/2005EP1534267A1 Pyrrolidine derivatives as tryptase inhibitors
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1351959B1 Novel pleuromutilin derivatives
06/01/2005EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005EP1188754B1 Substituted pyrazole compounds
06/01/2005EP1114030B1 Pyridine ketones useful as herbicides
06/01/2005EP1109965B1 Method of treating a textile
06/01/2005EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
06/01/2005EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors
06/01/2005EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
06/01/2005EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group
06/01/2005EP0937715B1 Tetrahydrobenzindole compounds
06/01/2005EP0708756B1 Substituted 2-phenylpyridines with herbicidal action
06/01/2005CN1622939A 9-aminoacridine derivatives and process for the preparation thereof
06/01/2005CN1622808A Treatment of gastrointestinal stromal tumors
06/01/2005CN1622806A Method for the treatment of overactive bladder
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1204137C Uracil compound and its appliance
06/01/2005CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same
05/2005
05/31/2005US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis
05/31/2005US6900329 MCH antagonists and their use in the treatment of obesity
05/31/2005US6900328 Stabilizer for polymers; photostability, oxidation resistance
05/31/2005US6900319 Carbo- and heterocyclic amidines
05/31/2005US6900317 Calcitonin gene related peptide antagonist; spray dried powder
05/31/2005US6900236 Cannabimimetic indole derivatives
05/31/2005US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents
05/31/2005US6900229 Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide
05/31/2005US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
05/31/2005US6900225 Quinolonecarboxylic acid derivative
05/31/2005US6900224 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology.
05/31/2005US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900207 N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient
05/31/2005US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders
05/31/2005US6900199 Central nervous system disorders; prevention amyloid deposits; Alzheimer's disease; Down sydrome
05/31/2005US6900196 Serine protease inhibitors
05/31/2005US6899739 Hair dyes
05/26/2005WO2005047899A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
05/26/2005WO2005047280A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
05/26/2005WO2005047279A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
05/26/2005WO2005047278A2 Substituted dihydroquinazolines ii
05/26/2005WO2005047267A1 Process for the synthesis of imidazoles
05/26/2005WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents
05/26/2005WO2005047259A1 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
05/26/2005WO2005047258A2 Methods and compositions for selectin inhibition
05/26/2005WO2005047255A1 Substituted nicotinoylcarbamates as pesticides
05/26/2005WO2005047253A1 Melanocortin receptor agonists
05/26/2005WO2005047251A1 Melanocortin receptor agonists
05/26/2005WO2005047250A1 N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders.
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005WO2005047247A1 Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005WO2005047246A1 Novel 1, 3-disubstituted azetidine deivatives for use as 5ht2a receptor ligands
05/26/2005WO2005047244A2 Inhibition of fgfr3 and treatment of multiple myeloma
05/26/2005WO2005047231A1 Non-symmetrical gelling agent
05/26/2005WO2005046698A1 Fused heterocyclic compounds
05/26/2005WO2005046685A1 Substituted piperidines for the treatment of metabolic syndrome
05/26/2005WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/26/2005WO2005046679A1 Immuno inhibitory pyrazolone compounds
05/26/2005WO2005046604A2 Heteroaryl-hydrazone compounds
05/26/2005WO2005046603A2 Pyridine compounds
05/26/2005WO2005046590A2 Methods for synthesizing quinolinone compounds
05/26/2005WO2005046589A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
05/26/2005WO2005046578A2 Isoquinolinone potassium channel inhibitors
05/26/2005WO2005030782A3 Carbene ligands and their use
05/26/2005WO2005019168A8 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
05/26/2005WO2005007642A3 Novel azaheterocyclic amides useful for treating pain
05/26/2005WO2004112719A8 Chemical compounds
05/26/2005WO2004111000A3 Piperidyl derivatives and their use as tachykinin antagonists
05/26/2005WO2004108686A3 Benzimidazole compounds having hypoglycemic activity
05/26/2005WO2004046136A9 Pyrazine compounds as crf modulators
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113579 Antitumor agents; formed by refluxing mixture of amonafide with acetic acid
05/26/2005US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases
05/26/2005US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes
05/26/2005US20050113423 Modulators of ATP-binding cassette transporters
05/26/2005US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens
05/26/2005US20050113413 Salt of 4-{N-[7-(3-(S)-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]- N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine (THRX 326151); storage stable; nonhygroscopic; free-flowing amorphous powder; dosage form; muscarinic receptor antagonist; overactive bladder; incontinence
05/26/2005US20050113407 for example, (Naphthalen-2-yl)-[6,7-dimethoxy-4-(1H-tetrazol-5-yl)-isoquinolin-1-yl]-methanone, (Naphthalen-1-yl)-[6,7-dimethoxy-4-(1H-tetrazol-5-yl)-isoquinolin-1-yl]-methanone
05/26/2005US20050113399 Platelet ADP receptor inhibitors; ADP (adenosine 5'-diphosphate); thrombosis; contain thien-2-yl-sulfonylurea groups; 1-(thiophen-2-ylsulfonyl)-3-(4-(7-fluoro-6-(sec or tert-amino)-1-oxo-(3,4-dihydro)isoquinolin-2(1H)-yl)aryl)urea
05/26/2005US20050113396 Na+/H++exchanger-3 (NHE-3) inhibitors; antiischemic agents
05/26/2005US20050113387 Pyrazine derivatives and pharmaceutical use thereof
05/26/2005US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
05/26/2005US20050113378 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
05/26/2005US20050113374 Benzodioxepine derivatives
05/26/2005US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample
05/26/2005US20050113370 Therapeutic substituted indazole derivatives
05/26/2005US20050113369 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
05/26/2005US20050113363 Hydroxyalkanoylaminolactams and related structures as inhibitors of A beta protein production
05/26/2005US20050113361 Amide derivatives as NMDA receptor antagonists
05/26/2005US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
1 ... 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 ... 1080